Eugenia Filippakopoulou: key facts
- Kind of voice
- Academic
- Role
- Imperial College Healthcare NHS Trust Hospital in London
- Quoted on
- Maternity & neonatal
- Press citations held
- 1
- Most recently quoted
- 30 Sept 2026
“evaluated the safety and efficacy of complement inhibitors and neonatal FC receptors blockers compared with placebo or standard care in adult patients with (AChR-Ab⁺) gMG”
Where Eugenia Filippakopoulou has been quoted
- Can Complement Inhibitors and Neonatal Fc Receptor Blockers Treat Generalized MG? | Rare Diseases Todaydocwirenews.com · 30 Sept 2026
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 30 Sept 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.